We are live on
!
Find out more
PCM
Prelude Capital Management Portfolio holdings
AUM
$1.31B
1-Year Est. Return
62.02%
This Fund
S&P 500
This Quarter
Est. Return
+1.02%
1 Year Est. Return
+62.02%
3 Year Est. Return
+164.16%
5 Year Est. Return
+274.13%
10 Year Est. Return
+2,470.2%
AUM
$1.53B
AUM Growth
-$1.13M
(-0.07%)
Cap. Flow
+$46.2M
Cap. Flow
% of AUM
3.01%
Top 10 Holdings %
Top 10 Hldgs %
22.12%
Holding
1,502
New
414
Increased
344
Reduced
260
Closed
396
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
NEWR
New Relic, Inc.
NEWR
|
+$10.5M |
| 2 |
Alibaba
BABA
|
+$10.4M |
| 3 |
ATVI
Activision Blizzard
ATVI
|
+$10.3M |
| 4 |
DQ
Daqo New Energy
DQ
|
+$8.18M |
| 5 |
KE Holdings
BEKE
|
+$8.14M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Green Brick Partners
GRBK
|
+$48.6M |
| 2 |
iShares Russell 2000 ETF
IWM
|
+$38.6M |
| 3 |
Vanguard S&P 500 ETF
VOO
|
+$35.9M |
| 4 |
JD.com
JD
|
+$13.5M |
| 5 |
ISEE
IVERIC bio, Inc. Common Stock
ISEE
|
+$12.8M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 14.68% |
| 2 | Healthcare | 10.56% |
| 3 | Consumer Discretionary | 9.55% |
| 4 | Industrials | 7.76% |
| 5 | Energy | 6.01% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1026
The Honest Company
HNST
$561M
| $63K | ﹤0.01% |
50,000
| – | – |
|
|
SBDS
1027
DELISTED
Solo Brands Inc
SBDS
| $62.2K | ﹤0.01% |
305
-133
| -30% | -$29K |
|
1028
SiriusXM
SIRI
$9.7B
| $61.9K | ﹤0.01% |
+1,370
| New | +$63.7K |
|
|
SKYT
1029
DELISTED
SkyWater Technology
SKYT
| $61.3K | ﹤0.01% |
+10,181
| New | +$77.2K |
|
|
IRD
1030
Opus Genetics
IRD
$302M
| $60.3K | ﹤0.01% |
+17,996
| New | +$72.3K |
|
1031
iQIYI
IQ
$1.31B
| $57.8K | ﹤0.01% |
+12,200
| New | +$63.6K |
|
|
CONN
1032
DELISTED
Conn's Inc.
CONN
| $57.1K | ﹤0.01% |
+14,452
| New | +$60K |
|
|
ALLK
1033
DELISTED
Allakos
ALLK
| $56.8K | ﹤0.01% |
25,000
| – | – |
|
1034
Seer Inc
SEER
$119M
| $55.9K | ﹤0.01% |
25,295
+400
| +2% | +$1.39K |
|
1035
Sight Sciences
SGHT
$424M
| $55.8K | ﹤0.01% |
+16,555
| New | +$109K |
|
|
RGLS
1036
DELISTED
Regulus Therapeutics
RGLS
| $55.2K | ﹤0.01% |
40,260
-400
| -1% | -$580 |
|
1037
ALX Oncology
ALXO
$285M
| $52.3K | ﹤0.01% |
+10,900
| New | +$59.1K |
|
|
NBP
1038
NovaBridge Biosciences American Depositary Shares
NBP
$205M
| $52.1K | ﹤0.01% |
+39,471
| New | +$86.7K |
|
1039
MaxCyte
MXCT
$130M
| $51.6K | ﹤0.01% |
+16,540
| New | +$66.5K |
|
|
DADA
1040
DELISTED
Dada Nexus
DADA
| $50.3K | ﹤0.01% |
+11,300
| New | +$60.1K |
|
1041
SunPower Inc
SPWR
$49.6M
| $49.9K | ﹤0.01% |
+24,222
| New | +$97.3K |
|
1042
Zevia
ZVIA
$108M
| $49.2K | ﹤0.01% |
+22,160
| New | +$65.1K |
|
1043
MacroGenics
MGNX
$259M
| $48.5K | ﹤0.01% |
10,400
-2,974
| -22% | -$14.8K |
|
1044
Perimeter Solutions
PRM
$5.65B
| $47.9K | ﹤0.01% |
10,542
-5,291
| -33% | -$29.5K |
|
|
GRCL
1045
DELISTED
Gracell Biotechnologies Inc. American Depositary Shares
GRCL
| $47K | ﹤0.01% |
+16,327
| New | +$59.7K |
|
1046
Relmada Therapeutics
RLMD
$484M
| $46.9K | ﹤0.01% |
15,642
-2,958
| -16% | -$8.79K |
|
1047
Telos
TLS
$302M
| $46.7K | ﹤0.01% |
19,536
-5,294
| -21% | -$12.1K |
|
|
KNTE
1048
DELISTED
Kinnate Biopharma Inc. Common Stock
KNTE
| $45.2K | ﹤0.01% |
32,309
+3,555
| +12% | +$8.54K |
|
1049
Nuvation Bio
NUVB
$2.32B
| $44.1K | ﹤0.01% |
32,932
-32,572
| -50% | -$54.2K |
|
1050
Porch Group
PRCH
$1.75B
| $43K | ﹤0.01% |
53,520
-4,653
| -8% | -$4.89K |
|
Similar funds
PFBT
CCP
SP
HCS
SPC
GPCM
MCM
CC
Prelude Capital Management's Q3 2023 Portfolio in Review
As of Q3 2023, Prelude Capital Management held 1,502 positions worth $1.53B, down 0.07% from $1.54B the previous quarter. Its ten largest holdings account for 22% of the portfolio.
Prelude Capital Management deployed $46.2M of net new capital in Q3 2023, opening 414 new positions and adding to 344 existing holdings. Its largest new stake was New Relic, Inc.: 130,823 shares worth $11.2M.
By sector, the portfolio is most concentrated in Technology at 15% of assets, up from 14% a quarter earlier, followed by Healthcare and Consumer Discretionary.
On the sell side, the largest reduction was iShares Russell 2000 ETF, an estimated $38.6M trimmed.
- Prelude Capital Management's largest Q3 2023 buy was New Relic, Inc.: 130,823 shares worth $11.2M.
- Prelude Capital Management added most to Alibaba in Q3 2023, an estimated $10.4M increase.
- Prelude Capital Management's biggest Q3 2023 reduction was iShares Russell 2000 ETF, cutting an estimated $38.6M.
- Prelude Capital Management fully exited Green Brick Partners in Q3 2023, selling an estimated $48.6M.
- Prelude Capital Management's ten largest holdings make up 22% of its $1.53B portfolio in Q3 2023.
- Prelude Capital Management opened 414 new positions and closed 396 in Q3 2023.
- Prelude Capital Management's portfolio value fell 0.07% quarter-over-quarter to $1.53B.
Based on Prelude Capital Management's 13F filing for Q3 2023, filed 14 Nov 2023.